Many leaders of the nation's biopharmaceutical industry are listening to America's patients, to their families and to their caregivers, who have told us that they find our medicines too expensive, and that they have lost trust in our industry.
Many leaders of the nation's biopharmaceutical industry are listening to America's patients, to their families and to their caregivers, who have told us that they find our medicines too expensive, and that they have lost trust in our industry.